Trademark: PYLVUE 2088245
Word
PYLVUE
ID
2088245
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
06 April 2020
Registration Date
06 April 2020
Cancellation Date
13 December 2023
Owner(s)
Service
Goods and Services:
Class 5:
Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis, prevention, treatment and monitoring of cancer.
Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis, prevention, treatment and monitoring of cancer.
Class 42:
Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer.
Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer.
Class 44:
Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services.
Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services.